Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Direxion Daily S&P 500 Bear 3X Shares ETF
SPXS
5
T-Rex 2x Inverse Tesla Daily Target ETF
TSLZ
US Stock MarketDetailed Quotes
DWTX Dogwood Therapeutics
- 5.530
- -0.130-2.30%
Close Apr 25 16:00 ET
- 5.710
- +0.180+3.25%
Pre 08:35 ET
10.57MMarket Cap-0.44P/E (TTM)
6.050High5.410Low352.48KVolume5.670Open5.660Pre Close2.02MTurnover22.67%Turnover RatioLossP/E (Static)1.91MShares29.28052wk High-1.04P/B8.60MFloat Cap1.62052wk Low--Dividend TTM1.56MShs Float417.750Historical High--Div YieldTTM11.31%Amplitude1.620Historical Low5.735Avg Price1Lot Size
About Dogwood Therapeutics Company
Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.
Company Profile
SymbolDWTX
Company NameDogwood Therapeutics
Listing DateDec 17, 2020
Founded2012
CEOMr. Gregory Duncan
MarketNASDAQ
Employees12
Fiscal Year Ends12-31
Address44 Milton Avenue
CityAlpharetta
ProvinceGeorgia
CountryUnited States of America
Zip Code30009
Phone1-866-620-8655
Websitehttp://www.dwtx.com
Company Executives
- Name
- Position
- Salary
- Gregory Duncan
- Chief Executive Officer and Chairman of the Board
- --
- Angela Walsh
- Chief Financial Officer, Corporate Secretary and Treasurer
- --
- Dr. Roger Michael Gendreau, M.D.,PhD
- Chief Medical Officer
- --
- Ralph Grosswald
- Senior Vice President, Operations
- --
- Ying Choi Alan Abel Yu
- Director
- --
- Dr. Melvin Toh, PhD
- Director
- --
- Dr. William L. Pridgen, M.D.
- Independent Director
- --
- John C. Thomas,Jr
- Independent Director
- --
- David Keefer
- Independent Director
- --
- Dr. Richard J. Whitley,M.D.
- Independent Director
- --
- Dr. Abel De La Rosa,PhD
- Independent Director
- --
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now